Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of...

24
Publication Issues GCP for clinical trials in India GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology

Transcript of Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of...

Page 1: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

Publication Issues

GCP for clinical trials in GCP for clinical trials in IndiaIndia

R.Raveendran

Chief Editor

Indian Journal of Pharmacology

Page 2: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

Why should ethics committee members bother about publication of study results?

Do ‘publication issues’ come under the purview of the ethics committee?

What issues (of publication) concern the ethics committee members?

What can ethics committee members do when guidelines are violated?

What is this talk about?

Page 3: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

Why should ethics committee members bother about publication of study results?

Page 4: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

Misreporting can cause considerable harm to patients and researchers.

Non-publication of research results can harm future patients.

Failure to report results of completed trials, whether positive or negative, negates the notion of social value.

Patients agree to participate in clinical research because of an

“understanding that the research could help future patients in a similar situation to them”

Page 5: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

Do ‘publication issues’ come under the purview of the ethics committee?

Page 6: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

6.2.1.8 the manner in which the results of the research will be reported and published;

Operational Guidelines for Ethics Committees That Review Biomedical

Research, World Health Organization, Geneva, 2000

6.2 Elements of the Review

Page 7: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

Indian Council of Medical ResearchGuidelines for preparing Standard Operating Procedures (SOP) for Institutional Ethics Committee for Human Research

10. Documentation:For a thorough and complete review, all research proposals should be submitted with the following documents :

17.Plans for publication of results – positive or negative- while maintaining the privacy and confidentiality of the study participants.

12. Elements of the reviewm. Plans for data analysis and reporting

Page 8: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

X. Principles of public domain whereby, the research and any further research, experimentation or evaluation in response to, and emanating from such research is brought into the public domain so that its results are generally made known through scientific and other publications subject to such rights as are available to the researcher and those associated with the research under the law in force at that time.

Ethical Guidelines for Biomedical Research on Human Subjects

INDIAN COUNCIL OF MEDICAL RESEARCH NEW DELHI 2000

STATEMENT OF GENERAL PRINCIPLES

Page 9: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

13. Plans for publication of results – positive or negative – while maintaining the privacy and confidentiality of the study participants.

Ethical Guidelines for Biomedical Research on Human Subjects

INDIAN COUNCIL OF MEDICAL RESEARCH NEW DELHI 2000

SUBMISSION OF APPLICATION

The researcher should submit an appropriate application in a prescribed format along with the study protocol at least three weeks in advance. The protocol should include the following : -

Page 10: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

“Researchers have a responsibility to make sure that the public is accurately informed about results without raising false hopes or expectations ……………………. …………… …………………… ……………………………… …………… ……………… …………………… …………….. .…………………………………………………………… that considerable time has to pass before these findings can be translated into human use”

Ethical Guidelines for Biomedical Research on Human Subjects

INDIAN COUNCIL OF MEDICAL RESEARCH NEW DELHI 2000

VII. RESEARCHER’S RELATIONS WITH THE MEDIA AND PUBLICATION PRACTICES

Page 11: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

What issues (of publication) concern the

ethics committee members?

Page 12: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

3. Authorship :

Issues concerning the ethics committee members

Review of Application / Protocol :

1. Statement of plans for publication/ dissemination of results : Peer reviewed journals – print or electronic Websites Open Access policy / institutional archives

2. Freedom to publish : Data ownership – Sponsor or

Researcher ? Veto power by sponsor –

Unacceptable Multicentric trial

Page 13: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

Beginning of trial :

Registration of clinical trials

Trial Registry – Facility to register ongoing trials

When to register? - before commencing enrollment

Where to register? – Govt body or private agencies

Why register? - advantages Problems –No national registry

Issues concerning the ethics committee members

Non-registration does NOT violate guidelines

Advise & Insist but don’t penalise

Page 14: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

Completion of trial :1.To publish or not to publish?

Negative resultsa)Journals - Publication biasb)Website – link to the registryc)Archives – self, institutionald)Electronic data banks

Exploratory studies – may not be published

Major flaws in the study – invalid data Failed trial

2. Confidentiality 3. Media relationship4. Duplicate / Redundant publication –

multicentric trial

Issues concerning the ethics committee members

Page 15: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

After submission or publication of trial results :

1. FraudData fudgingData fabricationData falsification

2. Authorship

Issues concerning the ethics committee members

Page 16: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

Violation of guidelines / publication

ethics

What can ethics committee members do?

Page 17: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

Violation of guidelines / publication ethics

What can ethics committee members do?

Review of Application / Protocol :

Return the protocol Researcher to correct & resubmit

Page 18: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

Ongoing trial: Registration

Ask for registration detailsAdvise/insist the researcher to register

Completed trial: Publication

Ask for publication details (e.g. reprints; website URL etc.)

Violation of guidelines / publication ethicsWhat can ethics committee members do?

Page 19: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

Nature 435, 737-738 (9 June 2005)

Page 20: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

Conducting research without ethics committee permission / Retrospective permission

Authorship – Ghost writingFraudPlagiarismRedundant or duplicate publicationNot declaring conflict of interest

Violation / misconduct may be reported by a reader or colleagues

Unethical publication practices

Page 21: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

If any violation detected / reported :

Take up the issue for discussion

Action :

recommend the head of the institute to initiate punitive measures

ban further submission of protocols by the researcher

ask the journal to withdraw the article and publish retraction

Violation of guidelines / publication ethicsWhat can ethics committee members do?

Page 22: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

Issues may be reported but not brought to the notice of the ethics committee

SOP – for dealing with publication issues and violation of publication ethics

Unnecessary delay in taking a decision to be avoided

Recommendations may not be implemented.

Ask the journal to withdraw the paper.

Violation of guidelines / publication ethicsWhat can ethics committee members do?

Page 23: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

HANK OU

Page 24: Publication Issues GCP for clinical trials in India R.Raveendran Chief Editor Indian Journal of Pharmacology.

The investigator should be asked to clarify :

whether the research sponsor has contractual rights to review and amend the content of the results before submission for publication;

the extent of any declared sponsor-review period between completion of the report and its submission for publication

whether the sponsor retains a veto power over results' dissemination.